PMID- 26546037 OWN - NLM STAT- MEDLINE DCOM- 20161213 LR - 20181202 IS - 1435-1463 (Electronic) IS - 0300-9564 (Linking) VI - 123 IP - 3 DP - 2016 Mar TI - Neonatal human retinal pigment epithelial cells secrete limited trophic factors in vitro and in vivo following striatal implantation in parkinsonian rats. PG - 167-77 LID - 10.1007/s00702-015-1480-7 [doi] AB - Human retinal pigment epithelial (hRPE) cell implants into the striatum have been investigated as a potential cell-based treatment for Parkinson's disease in a Phase II clinical trial that recently failed. We hypothesize that the trophic factor potential of the hRPE cells could potentially influence the function and/or survival of the implants and may be involved in an alternative mechanism of action. However, it is unclear if hRPE cells secreted trophic factors when handled in the manner used in the clinical Phase II trial. To address these questions, we investigated two neonatal hRPE cell lots, cultured in a similar manner to hRPE cells used in a Phase II clinical study, and longitudinally determined brain-derived neurotrophic factor (BDNF), fibroblast growth factor 2 (FGF2), and pigment epithelium-derived factor concentrations in vitro and following striatal implantation into 6-hydroxydopamine-lesioned rats. The results demonstrate short-lived BDNF and FGF2 concentrations in vitro from hRPE cells grown alone or attached to gelatin microcarriers (GM)s as well as limited trophic factor concentration differences in vivo following striatal implantation of hRPE-GM in 6-hydroxydopamine lesioned rats compared to sham (GM-only). The data suggest that trophic factors from neonatal hRPE cell implants likely did not participate in an alternative mechanism of action, which adds supports to a hypothesis that additional factors may have been necessary for the survival and/or function of hRPE implants and potentially the success of the Phase II clinical trial. FAU - Russ, Kaspar AU - Russ K AD - Pacific Parkinson's Research Centre, University of British Columbia, 2211 Wesbrook Mall, Vancouver, BC, V6T 2B5, Canada. kruss1@interchange.ubc.ca. AD - Research Laboratory for Stereology and Neuroscience, Bispebjerg-Frederiksberg Hospital, Bispebjerg Bakke 23, 2400, Copenhagen NV, Denmark. kruss1@interchange.ubc.ca. FAU - Flores, Joseph AU - Flores J AD - Pacific Parkinson's Research Centre, University of British Columbia, 2211 Wesbrook Mall, Vancouver, BC, V6T 2B5, Canada. FAU - Brudek, Tomasz AU - Brudek T AD - Research Laboratory for Stereology and Neuroscience, Bispebjerg-Frederiksberg Hospital, Bispebjerg Bakke 23, 2400, Copenhagen NV, Denmark. FAU - Doudet, Doris AU - Doudet D AD - Pacific Parkinson's Research Centre, University of British Columbia, 2211 Wesbrook Mall, Vancouver, BC, V6T 2B5, Canada. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20151106 PL - Austria TA - J Neural Transm (Vienna) JT - Journal of neural transmission (Vienna, Austria : 1996) JID - 9702341 RN - 0 (Nerve Growth Factors) SB - IM MH - Animals MH - Cells, Cultured MH - *Clinical Trials, Phase II as Topic MH - Corpus Striatum/*surgery MH - Enzyme-Linked Immunosorbent Assay MH - Female MH - Humans MH - Infant, Newborn MH - Male MH - Nerve Growth Factors/*metabolism MH - Parkinsonian Disorders/*surgery MH - Rats MH - Rats, Sprague-Dawley MH - Retinal Pigment Epithelium/cytology/metabolism/*transplantation OTO - NOTNLM OT - 6-Hydroxydopamine OT - Cell transplantation OT - Levodopa OT - Neonatal OT - Parkinson's disease OT - Retinal pigment epithelial cells OT - Trophic factors EDAT- 2015/11/08 06:00 MHDA- 2016/12/15 06:00 CRDT- 2015/11/08 06:00 PHST- 2015/08/21 00:00 [received] PHST- 2015/10/23 00:00 [accepted] PHST- 2015/11/08 06:00 [entrez] PHST- 2015/11/08 06:00 [pubmed] PHST- 2016/12/15 06:00 [medline] AID - 10.1007/s00702-015-1480-7 [pii] AID - 10.1007/s00702-015-1480-7 [doi] PST - ppublish SO - J Neural Transm (Vienna). 2016 Mar;123(3):167-77. doi: 10.1007/s00702-015-1480-7. Epub 2015 Nov 6.